We pick the stocks, we start the research, you ring the register!

10-13-2005 HEB - Hemispherx Biopharma

CURRENT PRICE:$2.00

TYPE OF PLAY: SECTOR MOMENTUM - Avian Flu

With the current news constantly harping on the avian flu pandemic, this Philadelphia company seems like a natural play. Their drug, Ampligen (R), enhances the effectiveness of Tamiflu against avian influenza. The Japanese are also currently pairing Ampligen with a drug of their own as a performance enhancer for a nasal flu vaccine combination therapy. The director purchased 10,000 shares on 8/18/2005. This company also has around 175 patents in various fields. While this company is largely speculative in nature, the momentum in this sector cannot be ignored.

LINKS FOR FURTHER READING:
HEB homepage
Tamiflu link
Japanese link
SEC filings for HEB
General HEB statistics